As of January 22, 2025, Altimmune (ALT) has a market cap of $0.49 billion USD. According to our data, Altimmune is ranked No.6134 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.49 B |
-3.61%
|
Dec 31, 2024 | $0.51 B |
-35.91%
|
Dec 29, 2023 | $0.80 B |
-31.61%
|
Dec 30, 2022 | $1.17 B |
79.59%
|
Dec 31, 2021 | $0.65 B |
-18.79%
|
Dec 31, 2020 | $0.80 B |
496.83%
|
Dec 31, 2019 | $0.13 B |
-8.25%
|
Dec 31, 2018 | $0.15 B |
-96.55%
|
Dec 29, 2017 | $4.25 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Inovio Pharmaceuticals
INO
|
$80.68 M |
0.000 M
|
USA
|
Vaxart
VXRT
|
$0.18 B |
-0.000 M
|
USA
|
Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
Arcturus Therapeutics
ARCT
|
$0.46 B |
-0.000 M
|
USA
|
Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
Telesis Bio
TBIO
|
$0.53 M |
0.000 M
|
USA
|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
USA
|
Ocugen
OCGN
|
$0.22 B |
-0.000 M
|
USA
|
Emergent BioSolutions
EBS
|
$0.59 B |
0.000 M
|
USA
|
Tonix Pharmaceuticals
TNXP
|
$58.40 M |
0.000 M
|
USA
|
Market Cap | = | ALT Stock Price | * | ALT Shares Outstanding |
= | $6.95 | * | 71.12 M | |
= | $0.49 B |